Centaurus Financial Inc. bought a new stake in Merck KGaA (OTCMKTS:MKGAF – Free Report) in the second quarter, HoldingsChannel reports. The fund bought 11,912 shares of the company’s stock, valued at approximately $1,531,000.
Several other institutional investors and hedge funds have also recently bought and sold shares of MKGAF. Frazier Financial Advisors LLC purchased a new position in Merck KGaA during the second quarter worth approximately $25,000. Rakuten Securities Inc. purchased a new stake in shares of Merck KGaA during the 2nd quarter valued at $27,000. Delos Wealth Advisors LLC purchased a new stake in shares of Merck KGaA during the 2nd quarter valued at $33,000. Solstein Capital LLC acquired a new stake in shares of Merck KGaA during the 2nd quarter worth $33,000. Finally, Burk Holdings LLC purchased a new position in shares of Merck KGaA in the 2nd quarter worth $39,000. Institutional investors and hedge funds own 0.10% of the company’s stock.
Merck KGaA Price Performance
Shares of Merck KGaA stock opened at $158.15 on Friday. Merck KGaA has a twelve month low of $116.68 and a twelve month high of $175.56. The stock has a market capitalization of $20.44 billion, a P/E ratio of 24.14 and a beta of 0.96. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. The business’s fifty day moving average price is $163.21 and its 200 day moving average price is $148.95.
Merck KGaA Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Recommended Stories
- Five stocks we like better than Merck KGaA
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
